- Home
- CREX vs ALGS Comparison
CREX vs ALGS Comparison
Compare CREX & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREX
- ALGS
- Stock Information
- Founded
- CREX N/A
- ALGS 2018
- Country
- CREX United States
- ALGS United States
- Employees
- CREX N/A
- ALGS N/A
- Industry
- CREX EDP Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CREX Technology
- ALGS Health Care
- Exchange
- CREX Nasdaq
- ALGS Nasdaq
- Market Cap
- CREX 33.5M
- ALGS 36.0M
- IPO Year
- CREX N/A
- ALGS 2020
- Fundamental
- Price
- CREX $3.36
- ALGS $7.20
- Analyst Decision
- CREX Strong Buy
- ALGS Strong Buy
- Analyst Count
- CREX 2
- ALGS 1
- Target Price
- CREX $8.00
- ALGS $70.00
- AVG Volume (30 Days)
- CREX 188.5K
- ALGS 156.2K
- Earning Date
- CREX 05-14-2025
- ALGS 08-05-2025
- Dividend Yield
- CREX N/A
- ALGS N/A
- EPS Growth
- CREX N/A
- ALGS N/A
- EPS
- CREX N/A
- ALGS N/A
- Revenue
- CREX $48,303,000.00
- ALGS $3,270,000.00
- Revenue This Year
- CREX $10.03
- ALGS N/A
- Revenue Next Year
- CREX $18.84
- ALGS N/A
- P/E Ratio
- CREX N/A
- ALGS N/A
- Revenue Growth
- CREX 1.68
- ALGS N/A
- 52 Week Low
- CREX $1.28
- ALGS $3.76
- 52 Week High
- CREX $5.20
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CREX 68.78
- ALGS 62.71
- Support Level
- CREX $2.80
- ALGS $5.47
- Resistance Level
- CREX $3.64
- ALGS $6.12
- Average True Range (ATR)
- CREX 0.46
- ALGS 0.59
- MACD
- CREX 0.05
- ALGS 0.21
- Stochastic Oscillator
- CREX 72.40
- ALGS 88.92
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.